13 Mar, 15:14
- Indian
No Data Found.
13 Mar, 15:14
- Global
NIKKEI 225
36966.05
(0.40)
HANG SENG
23463.27
(-0.58)
S&P
5612.5
(-0.08)
Login/Signup
Contact Us
Home
News
Markets
MF
IPO
Insurance
Real Estate
Research
Budget
Portfolio
Watchlist
Screener
Our Products
eMagazine
Capita School
Telefolio
Telefolio Gold
IER
Compendium
Capitaline AWS
Capitaline CSS
Capitaline NAV
TradeCues
Venture DB
Insurance
Research
Portfolio
Screener
eMagazine
Capita School
Telefolio
Telefolio Gold
IER
Compendium
Capitaline AWS
Capitaline CSS
Capitaline Nav
TradeCues
Venture DB
X
LOGIN HERE
Cancel
Overview
Background Information
Company Histoy
Board of Directors
Balance Sheet
Profit and Loss
Cash flow
Key Financial Ratios
Quarterly Results
Peer Comparison
MF Holding
Schemes Bought/Sold
Corporate Actions
- Board Meeting
- Bonus
- Splits
- Dividends
- Rights
- Capital Structure
- Book Closure
- AGM
- EGM
Share Price
Share Holding Pattern
Chairman's Speech
Directors Reports
Company News
Company Research
Result Analysis
Concall Highlights
Overview
Background Information
Locations
Balance Sheet
Profit and Loss
Cash Flow
Key Financial Ratios
Quarterly Results
Share Holding Pattern
Corporate Actions
company news
Announcements
Auditors Report
Directors Report
Chairmans Speech
Management Discussion
CSR Report
Notes to Accounts
Peer Comparison
boardmeeting
Bonus
Splits
Dividends
Rights
CapitalStructure
BookClosure
AGM
EGM
MF Holding
Schemes Bought/Sold
>Balance Sheet Aggregates
X
LOGIN HERE
Cancel
Jagsonpal Pharmaceuticals Ltd
You are Here :
Home
>
Markets
>
Company Information
>
Profit and Loss
BSE Code : 507789 | NSE Symbol : JAGSNPHARM | ISIN : INE048B01035 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
Profit and Loss
Standalone
Consolidated
Particulars (₹ Cr)
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Revenue From Operations
208.70
236.71
217.58
187.95
158.57
Sale of Products
208.70
236.71
217.58
187.88
158.57
Sale of Services
0.00
0.00
0.00
0.00
0.00
Income from Investment and Financial Services
0.00
0.00
0.00
0.00
0.00
Income from Insurance Operations
0.00
0.00
0.00
0.00
0.00
Other Operating Revenue
0.00
0.00
0.00
0.07
0.00
Less: Excise Duty / GST
0.00
0.00
0.00
0.00
0.00
Revenue From Operations - Net
208.70
236.71
217.58
187.95
158.57
Other Income
9.28
5.73
3.43
4.39
2.53
Total Revenue
217.98
242.45
221.01
192.34
161.09
Changes in Inventories
3.90
4.30
5.61
5.28
1.25
Cost of Material Consumed
22.10
31.21
31.91
38.63
36.78
Internally Manufactured Intermediates Consumed
0.00
0.00
0.00
0.00
0.00
Purchases of Stock-in-Trade
53.98
56.83
51.44
36.86
18.15
Employee Benefits
61.80
65.18
57.68
53.98
50.37
Total Other Expenses
43.86
45.04
45.92
34.11
43.47
Manufacturing / Operating Expenses
0.33
0.46
0.65
1.00
1.09
Administrative and Selling Expenses
41.66
42.01
43.23
31.88
38.34
Other Expenses
1.87
2.57
2.05
1.22
4.04
Finance Costs
0.81
0.41
0.29
0.51
0.51
Depreciation and Amortization
1.66
1.21
1.53
1.09
1.13
Total Expenses
188.11
204.18
194.37
170.47
151.68
Profit Before Exceptional Items and Tax
29.87
38.27
26.64
21.87
9.41
Exceptional Items Before Tax
0.00
-3.46
0.00
0.00
0.00
Profit Before Extraordinary Items and Tax
29.87
34.81
26.64
21.87
9.41
Extraordinary Items Before Tax
0.00
0.00
0.00
0.00
0.00
Other Adjustments Before Tax
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
29.87
34.81
26.64
21.87
9.41
Taxation
7.41
8.09
7.79
4.81
1.54
Current Tax
7.56
8.14
7.40
6.05
0.00
MAT Credit Entitlement
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-0.15
0.46
0.38
-1.23
-0.03
Other Tax
0.00
0.00
0.00
0.00
1.57
Adjust for Previous Year
0.00
-0.51
0.00
0.00
0.00
Profit After Tax
22.46
26.72
18.86
17.06
7.87
Extraordinary Items After Tax
0.00
0.00
0.00
0.00
0.00
Discontinued Operations After Tax
0.00
0.00
0.00
0.00
0.00
Profit / (Loss) from Discontinuing Operations
0.00
0.00
0.00
0.00
0.00
Tax Expenses of Discontinuing Operations
0.00
0.00
0.00
0.00
0.00
Profit Attributable to Shareholders
22.46
26.72
18.86
17.06
7.87
Adjustments to Net Income
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
Profit Attributable to Equity Shareholders
22.46
26.72
18.86
17.06
7.87
Earning Per Share - Basic
8.49
10.20
7.20
6.51
3.00
Earning Per Share - Diluted
8.47
10.20
7.20
6.51
3.00
Loading...
Tweets by CapitalMarket17